Skip to main content ( press enter )

Search

Reset filter
Displaying results 1902 - 1908 of 2920
Emerging female leaders awarded Lea Medal ahead of International Women's Day
Emerging female leaders awarded Lea Medal ahead of International Women's Day
Peter MacCallum Cancer Centre’s prestigious Lea Medal has this year been awarded to Dr Michelle Yong and Dr Junyun Lai. Ahead of International Women’s Day, the Peter MacCallum Cancer Centre hosted... Read more
OlympiA trial survival findings released - new treatment reduces breast cancer deaths by 32%
OlympiA trial survival findings released - new treatment reduces breast cancer deaths by 32%
Survival results for the global OlympiA breast cancer treatment clinical trial will be presented at a plenary session of the European Society of Medical Oncology this week. OlympiA was led in... Read more
Peter Mac patients to benefit from $185 million investment to fast-track treatments for rare and 'untreatable' cancers
Peter Mac patients to benefit from $185 million investment to fast-track treatments for rare and 'untreatable' cancers
Peter Mac is proud to be part of a private-public partnership announced yesterday, which will strengthen Australia's position at the forefront of the cancer treatment revolution. The Precision... Read more
Peter Mac supports Advance Care Planning Week
Peter Mac supports Advance Care Planning Week
Peter Mac is helping more Australians maintain control over their health care choices during Advance Care Planning Week (March 21-27). As Australia’s only public health service dedicated to the... Read more
Peter Mac's inaugural ProsTIC Preceptorship shares PSMA theranostics with the world
Peter Mac's inaugural ProsTIC Preceptorship shares PSMA theranostics with the world
Peter Mac proudly hosts the first ProsTIC Preceptorship this week, in partnership with the Prostate Cancer Foundation of Australia and the Prostate Cancer Foundation. Over 300 attendees from 29... Read more
"New hope" for patients with blood cancers not responding to treatment
Peter Mac’s Associate Professor Michael Dickinson has presented new data from a trial of the investigational blood cancer drug Glofitamab, at the annual meeting of the American Society of Clinical Oncology (ASCO)... Read more
Back to top